Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/23/2015 01/26/2015 01/27/2015 01/28/2015 01/29/2015 Date
12.23(c) 12.2(c) 11.93(c) 11.47(c) 11.27(c) Last
326 726 663 981 924 211 583 001 1 071 906 Volume
+2.69% -0.25% -2.21% -3.86% -1.74% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.Its product portfolio includes Fanapt and Tasimelteon.The Fanapt product is a compound for the treatment of schizophrenia, the... 
More about the company
Surperformance© ratings of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More Ratings
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 65,7 M
EBIT 2014 -57,4 M
Net income 2014 -57,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 138 M
EBIT 2015 -16,7 M
Net income 2015 -33,1 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 6,80x
Capi. / Sales 2015 3,24x
Capitalization 447 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
01/29 VANDA PHARMACEUTICALS : to Participate in the Canaccord Genuity Rare Disease, Bi..
01/23 VANDA PHARMACEUTICALS : Announces Listing of a New Fanapt® Patent in the FDA Ora..
01/16 VANDA PHARMACEUTICALS : Announces Listing of a New Fanapt® Patent in the FDA Ora..
01/02 VANDA PHARMACEUTICALS : Reaches Settlement with Novartis AG
2014 VANDA PHARMACEUTICALS : Other Events (form 8-K)
2014 VANDA PHARMACEUTICALS : Biotech Stocks Technical Data -- Gilead Sciences, Immuno..
2014 VANDA PHARMACEUTICALS : and Novartis to settle arbitration, with rights to Fanap..
2014 VANDA PHARMACEUTICALS : Settle Fanapt Arbitration With Novartis
More news
Sector news Bio Therapeutic Drugs
01/29DJValeant to Buy Prostate-Cancer Drug From Dendreon
01/29DJValeant in Deal to Buy Prostate-Cancer Drug Provenge From Dendreon
01/29 ALNYLAM PHARMACEUTICALS : Thursday 1/29 Insider Buying Report: ALNY, SSB
Plus d'actualités du secteur Bio Therapeutic Drugs


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF